BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23679319)

  • 1. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
    Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
    Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea.
    Cho E; Kang MH; Choi KS; Suh M; Jun JK; Park EC
    Asian Pac J Cancer Prev; 2013; 14(4):2533-40. PubMed ID: 23725170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of Korea's National Cervical Cancer Screening Program.
    Cho E; Kang MH; Choi KS; Suh M; Jun JK; Park EC
    Asian Pac J Cancer Prev; 2013; 14(7):4329-34. PubMed ID: 23991998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of breast cancer screening in women on dialysis.
    Wong G; Howard K; Chapman JR; Craig JC
    Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
    Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
    Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-schedule mammography rescreening in the National Cancer Screening Program for breast cancer in Korea.
    Oh D; Jung DW; Jun JK; Jung KW; Lee HY; Park EC; Choi KS
    Asian Pac J Cancer Prev; 2011; 12(11):2865-70. PubMed ID: 22393955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost.
    Suh YS; Lee J; Woo H; Shin D; Kong SH; Lee HJ; Shin A; Yang HK
    Cancer; 2020 Jan; 126(9):1929-1939. PubMed ID: 32031687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai].
    Wu F; Mo M; Qin XX; Fang H; Zhao GM; Liu GY; Chen YY; Cao ZG; Yan YJ; Lyu LL; Xu WH; Shao ZM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Dec; 38(12):1665-1671. PubMed ID: 29294584
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
    Rim SH; Allaire BT; Ekwueme DU; Miller JW; Subramanian S; Hall IJ; Hoerger TJ
    Cancer Causes Control; 2019 Aug; 30(8):819-826. PubMed ID: 31098856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
    Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
    Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
    Allaire BT; Ekweme D; Hoerger TJ; DeGroff A; Rim SH; Subramanian S; Miller JW
    Cancer Causes Control; 2019 Sep; 30(9):923-929. PubMed ID: 31297693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost- Effectiveness of Mammography Screening Program in a Resource-Limited Post-Soviet Country of Kazakhstan.
    Salikhanov I; Crape B; Howie P
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):3153-3160. PubMed ID: 31653167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of mammography screening for Chinese women.
    Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
    Cancer; 2007 Aug; 110(4):885-95. PubMed ID: 17607668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
    Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
    Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budget Impact of the Accreditation Program for Clinical Laboratories on Colorectal Cancer Screening via Fecal Immunochemical Testing: Results from the National Cancer Screening Program in Korea.
    Jun JK; Sung NY; Song SH; Hong S; Jang MA; Song J; Kim JH; Min WK; Lee YK
    Ann Lab Med; 2018 May; 38(3):249-254. PubMed ID: 29401560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of prostate cancer screening test as a national cancer screening program in South Korea.
    Shin S; Kim YH; Hwang JS; Lee YJ; Lee SM; Ahn J
    Asian Pac J Cancer Prev; 2014; 15(8):3383-9. PubMed ID: 24870726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Health economics analysis of breast cancer screening].
    Boncz I; Sebestyén A; Gulácsi L; Pál M; Dózsa C
    Magy Onkol; 2003; 47(2):149-54. PubMed ID: 12975661
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.